Related Experiment Video
Updated: Dec 31, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
834
Weight loss supplement causing acute heart block in a child
Daniel R O'Brien1, Vivian Szymczuk2, Cecilia A Albaro2
1Department of Internal Medicine/Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, IL, USA.
Cardiology in the Young
|January 7, 2020
Summary
A teenager experienced severe heart block and toxicity after consuming a candlenut seed for weight loss. This case highlights the unknown risks of herbal supplements and the need for medical awareness.
Area of Science:
- Cardiology
- Toxicology
- Herbal Medicine
Background:
- Herbal weight loss supplements pose potential health risks.
- Aleurites moluccana (Candlenut) is used in traditional medicine and for weight loss.
- Adverse effects of herbal remedies are often underreported.
Observation:
- A 16-year-old male presented with vomiting, somnolence, and chest pain.
- Electrocardiogram revealed 2nd-degree heart block, worsening over time.
- Symptoms mimicked digoxin toxicity.
Findings:
- Ingestion of a single Aleurites moluccana seed led to significant cardiac toxicity.
- The patient's condition improved with supportive care in the ICU.
- Complete resolution of symptoms occurred within 48 hours.
Implications:
- Physicians must consider herbal supplement toxicity in patients with unexplained symptoms.
- Increased awareness and reporting of adverse events from herbal products are crucial.
- Further research is needed to understand the toxicological profiles of commonly used herbal supplements.
Related Concept Videos
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.4K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K
01:22Heart Failure Drugs: β-Blockers
702
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
702
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.6K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.6K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.3K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K